Effects of Ebselen (PZ 51) on Ischaemic Brain Oedema After Focal Ischaemia in Cats
Part of the
book series (NEUROCHIRURGICA, volume 51)
Using a transorbital middle cerebral artery (MCA) occlusion model in cats, we evaluated the anti-oedema effects of a new anti-inflammatory agent, ebselen (PZ 51), on ischaemic cortical oedema caused by prolonged ischaemia and recirculation. Local cerebral blood flow was measured by the hydrogen clearance method in the MCA territory and the corresponding cortical specific gravity was assessed by a microgravimetric technique. Ebselen had no significant effect on normal and ischaemic lCBF, while it significantly ameliorated post-ischaemic hypoperfusion following recirculation. In the severely ischaemic regions, microgravimetry showed the beneficial effects on the ischaemic oedema caused by prolonged ischaemia and recirculation as well. Although the exact site of action is undetermined in this study, the observed effects of ebselen may be ascribed to this agent’s broad-spectrum of anti-inflammatory activities.
KeywordsMiddle Cerebral Artery Middle Cerebral Artery Occlusion Focal Ischaemia Drug Treated Group Middle Cerebral Artery Territory
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Asano T, Koide T, Gotoh O, Johshita H, Hanamura T, Shigeno T, Takakura K (1989) The role of free radicals and eicosanoids in the pathogenetic mechanism underlying ischaemic brain oedema. Mol Chem Neuropathol 10: 101–133PubMedCrossRefGoogle Scholar
Johshita H, Asano T, Hanamura T, Takakura K (1989) Effect of indomethacin and a free radical scavenger on cerebral blood flow and oedema after cerebral artery occlusion in cats. Stroke 20: 788–794PubMedCrossRefGoogle Scholar
Muller A, Cadenas E, Graf P, Sies H (1984) A novel biologically active selenoorganic compound-I. Glutathione peroxidase activity in vitro
and antioxidant capacity of PZ 51 (ebselen). Biochem Pharmacol 33: 3235–3240PubMedCrossRefGoogle Scholar
Cotgreave IA, Duddy SK, Kass GN, Thompson D, Moldeus P (1989) Studies on the anti-inflammatory activity of ebselen. Biochem Pharmacol 38: 649–656PubMedCrossRefGoogle Scholar
Kuhl P, Borbe HO, Romer A, Fischer H, Parnham MJ (1985) Selective inhibition of leukotriene B4 formation by ebselen: a novel approach to antiinflammatory therapy. Agents and Actions 17: 366–367CrossRefGoogle Scholar